NHG-Richtlijnen
NHG-Standaard
M101
1.2
november 2012
juni 2024
S. Huid en subcutis

Begrippen

Naar Volledige tekst ›

Richtlijnen diagnostiek

Naar Volledige tekst ›

Anamnese

Naar Volledige tekst ›

Lichamelijk onderzoek

Naar Volledige tekst ›

Aanvullend onderzoek

Naar Volledige tekst ›

Evaluatie

Naar Volledige tekst ›

Richtlijnen beleid

Naar Volledige tekst ›

Voorlichting

Naar Volledige tekst ›

Medicamenteuze behandeling

Naar Volledige tekst ›

Controles

Naar Volledige tekst ›

Verwijzing

Naar Volledige tekst ›

Belangrijkste wijzigingen

Naar Samenvatting ›

Kernboodschappen

Naar Samenvatting ›

Inleiding

Naar Samenvatting ›

Scope

Naar Samenvatting ›

Buiten de scope

Naar Samenvatting ›

Afstemming

Naar Samenvatting ›

Achtergronden

Naar Samenvatting ›

Begrippen

Naar Samenvatting ›

Lichen sclerosus

Naar Samenvatting ›

Plaveiselcelcarcinoom

Naar Samenvatting ›

Epidemiologie

Naar Samenvatting ›

Etiologie

Naar Samenvatting ›

Klinisch beeld

Naar Samenvatting ›

Natuurlijk beloop en prognose

Naar Samenvatting ›

Richtlijnen diagnostiek

Naar Samenvatting ›

Anamnese

Naar Samenvatting ›

Lichamelijk onderzoek

Naar Samenvatting ›

Aanvullend onderzoek

Naar Samenvatting ›

Evaluatie

Naar Samenvatting ›

Richtlijnen beleid

Naar Samenvatting ›

Voorlichting

Naar Samenvatting ›

Thuisarts

Naar Samenvatting ›

Niet-medicamenteuze behandeling

Naar Samenvatting ›

Medicamenteuze behandeling

Naar Samenvatting ›

Bijwerkingen

Naar Samenvatting ›

Aanbevelingen

Naar Samenvatting ›
2e lijn
Naar Samenvatting ›

Lokale behandeling

Naar Samenvatting ›

Controle en verwijzing

Naar Samenvatting ›

Controles

Naar Samenvatting ›

Verwijzing

Naar Samenvatting ›

Samenwerking

Naar Samenvatting ›

Referenties

  1. Nederlandse Vereniging voor Dermatologie en Venereologie. Richtlijn Anogenitale lichen sclerosus. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2012. Geraadpleegd maart 2012.
  2. NVDV. Richtlijn lichen sclerosus (2021) Ga naar bron
  3. Van Rossum MM, Van der Avoort IAM, De Hoop D, Dukel L, Van der Vleuten CJM, De Hullu JA. Lichen sclerosus. Ned Tijdschr Geneeskd 2007;151:1225-31.
  4. Nelson DM, Peterson AC. Lichen sclerosus: epidemiological distribution in an equal access health care system. J Urol 2011;185:522-5.
  5. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995;32:393-416.
  6. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999;353:1777-83.
  7. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971;57:9-30.
  8. Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005;50:477-80.
  9. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007;178:2268-76.
  10. Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004;140:702-6.
  11. Smith YR, Haefner HK. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004;5:105-25.
  12. Pock L. Koebner phenomenon in lichen sclerosus et atrophicus. Dermatologica 1990;181:76-7.
  13. Tegner E, Vrana I. Lichen sclerosus et atrophicus appearing in old scars of burns from welding sparks. Acta Derm Venereol 2001;81:211.
  14. Isaac R, Lyn M, Triggs N. Lichen sclerosus in the differential diagnosis of suspected child abuse cases. Pediatr Emerg Care 2007;23:482-5.
  15. Warrington SA, De San Lazaro C. Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child 1996;75:512-6.
  16. Priestley BL, Bleehen SS. Lichen sclerosus and sexual abuse. Arch Dis Child 1990;65:335.
  17. Jenny C, Kirby P, Fuquay D. Genital lichen sclerosus mistaken for child sexual abuse. Pediatrics 1989;83:597-9.
  18. Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000;142:481-4.
  19. San LC. Lichen sclerosis. Arch Dis Child 1990;65:1184.
  20. Swarte RM, Hack WW, Van den Hoogenband HM. Lichen sclerosus et atrophicus als oorzaak van genitale afwijkingen bij een meisje. Ned Tijdschr Geneeskd 1997;141:2411-2.
  21. Von Muhlendahl KE. Suspected sexual abuse in a 10-year-old girl. Lancet 1996;348:30.
  22. Al-Khenaizan S, Almuneef M, Kentab O. Lichen sclerosus mistaken for child sexual abuse. Int J Dermatol 2005;44:317-20.
  23. Priestley BL. Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. Br Med J (Clin Res Ed) 1987;295:311.
  24. Bilo RA, De Waard-van der Spek FB, Okkerse A, Oranje AP. Anogenitale klachten bij kinderen. Gaat het om seksueel misbruik? Ned Tijdschr Geneeskd 1994;138:1457-9.
  25. Harrington CI. Lichen sclerosus. Arch Dis Child 1990;65:335.
  26. Maronn ML, Esterly NB. Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics 2005;115:e230-e232.
  27. Wood PL, Bevan T. Lesson of the week child sexual abuse enquiries and unrecognised vulvar lichen sclerosus et atrophicus. BMJ 1999;319:899-900.
  28. Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, et al. Circumcision and genital dermatoses. Arch Dermatol 2000;136:350-4.
  29. Ledwig PA, Weigand DA. Late circumcision and lichen sclerosus et atrophicus of the penis. J Am Acad Dermatol 1989;20:211-4.
  30. HCUP (Healthcare Cost and Utilization Project). Circumcisions performed in U.S. community hospitals, 2005. Ga naar bron
  31. Brown AR, Dunlap CL, Bussard DA, Lask JT. Lichen sclerosus et atrophicus of the oral cavity: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:165-70.
  32. Diakomanolis ES, Haidopoulos D, Syndos M, Rodolakis A, Stefanidis K, Chatzipapas J, et al. Vulvar lichen sclerosus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0.05%. Eur J Gynaecol Oncol 2002;23:519-22.
  33. Barbagli G, Palminteri E, Balo S, Vallasciani S, Mearini E, Costantini E, et al. Lichen sclerosus of the male genitalia and urethral stricture diseases. Urol Int 2004;73:1-5.
  34. Bochove-Overgaauw DM, Gelders W, De Vylder AMA. Routine biopsies in pediatric circumcision: (non) sense? J Pediatr Urol 2009;5:178-80.
  35. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001;44:803-6.
  36. Vincent MV, Mackinnon E. The response of clinical balanitis xerotica obliterans to the application of topical steroid-based creams. J Pediatr Surg 2005;40:709-12.
  37. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med 2002;47:706-9.
  38. Smith SD, Fischer G. Paediatric vulvar lichen sclerosus. Australas J Dermatol 2009;50:243-8.
  39. Van de Nieuwenhof HP, Van der Avoort IAM, De Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 2008;68:131-56.
  40. Neill SM, Tatnall FM, Cox NH; British Association of Dermatologists. Guidelines for the management of lichen sclerosus. Br J Dermatol. 2002 Oct;147(4):640-9. Review.
  41. Tasker GL, Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol. 2003 Mar;28(2):128-33. Review.
  42. Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med. 1995 May;40(5):351-4.
  43. Jones RW, Sadler L, Grant S, Whineray J, Exeter M, Rowan D. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study. J Reprod Med 2004;49:808-11.
  44. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004;140:709-12.
  45. Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998a;29:932-48.
  46. Van der Meijden WI, Ter Harmsel WA. Vulvapathologie. Assen: Koninklijke Van Gorcum BV, 2007.
  47. Fons G, Hyde SE, Buist MR, Schilthuis MS, Grant P, Burger MP, et al. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 2009;19:1276-80.
  48. Heineman MJ, Evers JLH, Massuger LFAG, Steegers EAP. Obstetrie en gynaecologie. De voortplanting van de mens. 6de dr. Amsterdam: Elsevier Gezondheidszorg, 2006.
  49. Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol 1999;41:911-4.
  50. Barbagli G, Palminteri E, Mirri F, Guazzoni G, Turini D, Lazzeri M. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol 2006;175:1359-63.
  51. Rook AJ, Wilkinson DS, Ebling FJG, Champion RH. Textbook of Dermatology. 6th ed. Oxford: Blackwell Science, 1998.
  52. Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998b;29:932-48.
  53. Scurry J, Whitehead J, Healey M. Histology of lichen sclerosus varies according to site and proximity to carcinoma. Am J Dermatopathol 2001;23:413-8.
  54. Margesson LJ. Overview of treatment of vulvovaginal disease. Skin Therapy Lett 2011;16:5-7.
  55. Saunders NA, Haefner HK. Vulvar lichen sclerosus in the elderly: pathophysiology and treatment update. Drugs Aging 2009;26:803-12.
  56. Goudswaard AN, In 't Veld CJ, Kramer WLM. Handboek verrichtingen in de huisartsenpraktijk. Houten/Utrecht: Prelum, 2009.
  57. Zuber TJ. Punch biopsy of the skin. Am Fam Physician 2002;65:1155-2, 1164.
  58. Nyirjesy P. lichen sclerosus and other conditions mimicking vulvovaginal candidiasis. Curr Infect Dis Rep 2002;4:520-4.
  59. Hornor G. Common conditions that mimic findings of sexual abuse. J Pediatr Health Care 2009;23:283-8.
  60. Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev 2011;CD008240.
  61. Bracco GL, Carli P, Sonni L, Maestrini G, De Marco A, Taddei GL, et al. Clinical and histologic effects of topical treatments of vulvar lichen sclerosus. A critical evaluation. J Reprod Med 1993;38:37-40.
  62. Kiss A, Csontai A, Pirot L, Nyirady P, Merksz M, Kiraly L. The response of balanitis xerotica obliterans to local steroid application compared with placebo in children. J Urol 2001;165:219-20.
  63. Dalziel KL, Wojnarowska F. Long-term control of vulvar lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993;38:25-7.
  64. Cattaneo A, De Marco A, Botti E, Sonni L, Carli P, Taddei GL. Topical mometasone furoate for vulvar lichen sclerosus. J Reprod Med 2003;48:444-8.
  65. British Association of Dermatologists. Lichen sclerosus (2010). Ga naar bron
  66. Corazza M, Borghi A, Minghetti S, Toni G, Virgili A. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial. JEADV 2016;30:956-61.
  67. Virgili A, Minghetti S, Borghi A, Corazza M. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. BJD 2013;168:1316-24.
  68. Lee A, Bradford J, Fischer G. Long-term Management of Adult Vulvar Lichen Sclerosus. A prospective cohort study of 507 Women. JAMA Dermatol 2015;151:1061-7.
  69. Simonart T, Lahaye M, Simonart JM. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease. Menopause 2008;15:74-7.
  70. Nederlandse Vereniging voor Dermatologie en Venereologie. Richtlijn Dermatocorticosteroiden. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2000. Ga naar bron
  71. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. UVA1 phototherapy for genital lichen sclerosus. Clin Exp Dermatol 2006;31:343-7.
  72. Hillemanns P, Untch M, Prove F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999;93:71-4.
  73. Nisticò SP, Saraceno R, Schipani C, Costanzo A, Chimenti S. Different applications of monochromatic excimer light in skin diseases. Photomed Laser Surg. 2009 Aug;27(4):647-54.
  74. Zawislak AA, McCluggage WG, Donnelly RF, Maxwell P, Price JH, Dobbs SP, et al. Response of vulvar lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed 2009;25:111-3.
  75. Virgilli A, Corazza M, Bianchi A, Mollica G, Califano A. Open study of topical 0.025% Tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J Reprod Med 1995;6:614-5.
  76. Bulbul BE, Turan H, Tunali S, Toker SC, Saricaoglu H. Open-label trial of cyclosporine for vulvar lichen sclerosus. J Am Acad Dermatol 2007;57:276-8.
  77. Bousema MT, Romppanen U, Geiger JM, Baudin M, Vaha-Eskeli K, Vartiainen J, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994;30:225-31.
  78. Ioannides D, Lazaridou E, Apalla Z, Sotiriou E, Gregoriou S, Rigopoulos D. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo controlled study. J Urol 2010;183:1395-9.
  79. Funaro D, Lovett A, Leroux N, et al. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. JAAD 2014;71:84-91.
  80. Goldstein AT, Creasey A, Pfau R, et al. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. JAAD 2011;64:e99-e104.
  81. Oskay T, Sezer HK, Genc C, Kutluay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol 2007;46:527-32.
  82. Ayhan A, Guven ES, Guven S, Sakinci M, Dogan NU, Kucukali T. Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia. Acta Obstet Gynecol Scand 2007;86:715-9.
  83. Cattaneo A, Carli P, De Marco A, Sonni L, Bracco G, De Magnis A, et al. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996;41:99-102.
  84. Joura EA, Zeisler H, Bancher-Todesca D, Sator MO, Schneider B, Gitsch G. Short-term effects of topical testosterone in vulvar lichen sclerosus. Obstet Gynecol 1997;89:297-9.
  85. Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991;78:1046-9.
  86. Paslin D. Androgens in the topical treatment of lichen sclerosus. Int J Dermatol 1996;35:298-301.
  87. Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994;46:53-6.
  88. Skierlo P, Heise H. Testosteronpropionat-Salbe - ein Therapieversuch beim Lichen sclerorus et atrophicus. Hautarzt 1987;38:295-7.
  89. Leone M, Gerbaldo D, Caldana A, Leone MM, Capitanio GL. Progesterone topically adiministered influences epidermal growth factor immunoreactivity in vulvar tissue from patients with lichen sclerosus. The Cervix 1993;11:25-7.
  90. Balasubramaniam P, Lewis FM. Long-term follow-up of patients with lichen sclerosus: does it really happen? J Obstet Gynaecol 2007;27:282.
  91. Abramov Y, Elchalal U, Abramov D, Goldfarb A, Schenker JG. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 1996;51:193-9.
  92. Van Straalen WR, Hage JJ, Bloemena E, Glastra A. Plastische chirurgie als ultimum refugium bij lichen sclerosus. Ned Tijdschr Geneeskd 1997;141:992-8.
  93. Kulkarni S, Barbagli G, Kirpekar D, Mirri F, Lazzeri M. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55:945-54.
  94. August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol 1980;103:667-70.
  95. Kastner U, Altmeyer P. Kryochirurgie-ultima ratio oder chirurgische Alternative beim vulvaren Lichen sclerosus et atrophicus (LSAV)? J Dtsch Dermatol Ges 2003;1:206-11.
  96. Stucker M, Grape J, Bechara FG, Hoffmann K, Altmeyer P. The outcome after cryosurgery and intralesional steroid injection in vulvar lichen sclerosus corresponds to preoperative histopathological findings. Dermatology 2005;210:218-22.
  97. Paniel BJ, Truc JB, Robichez B, Poitout P. Vulvo-perineoplastie. Presse Med 1984;13:1895-8.
  98. Paniel BJ. Surgical procedures in benign vulvar disease. In: Ridley CM, Neill SM, editors. The vulva. Oxford: Blackwell Science, 1999: 277-91.
  99. Rouzier R, Haddad B, Deyrolle C, Pelisse M, Moyal-Barracco M, Paniel BJ. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol 2002;186:49-52.
  100. Kennedy CM, Dewdney S, Galask RP. Vulvar granuloma fissuratum: a description of fissuring of the posterior fourchette and the repair. Obstet Gynecol 2005;105:1018-23.
Fluor vaginalis: diagnostiek
NHG-werkgroep:
Glansdorp A, Peerden M, Van Kimmenade R, Vliet Vlieland C, De Vries L, Hooymans C, Loogman M, Stam H, De Vries L, Wiersma T
6 gerelateerde lacunes
E-mail